Chagas' disease.
Chagas' disease, caused by Trypanosoma cruzi, is an important cause of morbidity in many countries in Latin America. The important modes of transmission are by the bite of the reduviid bug and blood transfusion. The organism exists in three morphological forms: trypomastigotes, amastigotes, and epimastigotes. The mechanism of transformation and differentiation is currently being explored, and signal transduction pathways of the parasites may be involved in this process. Parasite adherence to and invasion of host cells is a complex process involving complement, phospholipase, penetrin, neuraminidase, and hemolysin. Two clinical forms of the disease are recognized, acute and chronic. During the acute stage pathological damage is related to the presence of the parasite, whereas in the chronic stage few parasites are found. In recent years the roles of tumor necrosis factor, gamma interferon, and the interleukins in the pathogenesis of this infection have been reported. The common manifestations of chronic cardiomyopathy are arrhythmias and thromboembolic events. Autoimmune, neurogenic, and microvascular factors may be important in the pathogenesis of the cardiomyopathy. The gastrointestinal tract is another important target, and "mega syndromes" are common manifestations. The diagnosis and treatment of this infection are active areas of investigation. New serological and molecular biological techniques have improved the diagnosis of chronic infection. Exacerbations of T. cruzi infection have been reported for patients receiving immuno-suppressive therapy and for those with AIDS.
Tanowitz
H B
HB
Department of Pathology, Albert Einstein College of Medicine, Bronx, New York.
Kirchhoff
L V
LV
Simon
D
D
Morris
S A
SA
Weiss
L M
LM
Wittner
M
M
D000818:Animals; D001803:Blood Transfusion; D002598:Chagas Cardiomyopathy / Q000209:etiology / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D014355:Chagas Disease / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D000075202:Contraindications; D005767:Gastrointestinal Diseases / Q000209:etiology*; D006801:Humans; D009422:Nervous System Diseases / Q000209:etiology; D014349:Trypanosoma cruzi / Q000254:growth & development / Q000472:pathogenicity*